INTERNATIONAL LYMPHOEDEMA FRAMEWORK
The charity's objectives and activities are to undertake, manage and promote research, education, training and implementation of research based practice relating to clinical conditions involving or relating to lymphoedema and other similar acute or chronic conditions in community or hospital settings and other matters relating to health.
Financial health, per its FY2024 accounts
The accounts state that the charity reported a surplus of £37,214 for the year ended 29 December 2024, bringing total unrestricted reserves to £65,290. The trustees confirm that the financial statements are prepared on a going concern basis, with no material uncertainties identified regarding the charity's ability to continue operations.
What the accounts disclose
Trustees
- PROFESSOR CHRISTINE JOY MOFFATTchair
- David Howard Keast
- NURSE SUSAN JENSEN NORREGAARD
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 29/12/2024 | £87k | £50k |
| 30/12/2023 | £370k | £447k |
| 31/12/2022 | £134k | £135k |
| 31/12/2021 | £190k | £182k |
| 31/12/2020 | £118k | £92k |
Common questions
Is INTERNATIONAL LYMPHOEDEMA FRAMEWORK financially healthy?
Per its FY2024 accounts: The accounts state that the charity reported a surplus of £37,214 for the year ended 29 December 2024, bringing total unrestricted reserves to £65,290. The trustees confirm that the financial statements are prepared on a going concern basis, with no material uncertainties identified regarding the charity's ability to continue operations. Its FY2024 accounts were independently examined.